Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine With Hydromorphone for Brachial Plexus Block
ChiCTR-IPR-16008654Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydromorphone and ropivacaine in postoperative pain, perioperative pain and None (4 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Onset time of sensory and motor block in radial, ulnar, and median nerves, Duration of sensory and motor block in radial, ulnar, and median nerves and 1 more. Started Jun 2016; status: recruiting.
02
Drugs
hydromorphoneropivacaine
03
Conditions
postoperative painperioperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-16008654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008654.